Literature DB >> 32754944

Lung-Specific Risk Factors Associated With Incident Hip Fracture in Current and Former Smokers.

Jessica Bon1, Seyed Mehdi Nouraie2, Kenneth J Smith3, Mark T Dransfield4, Merry-Lynn McDonald4, Eric A Hoffman5,6,7, John D Newell5,6,7, Alejandro P Comellas8, Punam K Saha5,6,7, Russell P Bowler9, Elizabeth A Regan10.   

Abstract

Hip fractures are associated with significant morbidity and mortality in smokers with lung disease, but whether lung-specific factors are associated with fracture risk is unknown. Our goal was to determine whether lung-specific factors associate with incident hip fracture and improve risk discrimination of traditional fracture risk models in smokers. The analysis consisted of a convenience sample of 9187 current and former smokers (58,477 participant follow-up years) participating in the Genetic Epidemiology of chronic obstructive pulmonary disease (COPD) longitudinal observational cohort study. Participants were enrolled between 2008 and 2011 with follow-up data collection through July 2018. Traditional risk factors associated with incident hip fracture (n = 361) included age, female sex, osteoporosis, prevalent spine and hip fracture, rheumatoid arthritis, and diabetes. Lung-specific risk factors included post-bronchodilator percent forced expiratory volume in 1 s (FEV1 %) predicted (OR, 0.95; 95% CI, 0.92-0.99 for each 10% increase), Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification (OR, 1.09; 95% CI, 1.002-1.19 for each higher stage), presence of CT-determined emphysema (OR, 1.34; 95% CI, 1.06-1.69), symptom scores (OR, 1.10; 95% CI, 1.03-1.19 for each higher unit score), 6-min walk distance (OR, 0.92; 95% CI, 0.90-0.95 for each 30-m increase), body mass index, airflow obstruction, dyspnea, and exercise (BODE) index (OR, 1.07; 95% CI, 1.01-1.13 for each higher unit score), total exacerbations (OR, 1.13; 95% CI, 1.10-1.16 per exacerbation), and annual exacerbations (OR, 1.37; 95% CI, 1.21-1.55 per exacerbation). In multivariable modeling, age, black race, osteoporosis, prevalent hip and spine fracture, rheumatoid arthritis, and diabetes were associated with incident hip fracture. The presence of emphysema, 6-min walk distance, and total number of exacerbations added to traditional models improved risk discrimination (integrated discrimination improvement [IDI] values 0.001 [95% CI, 0.0003-0.002], 0.001 [95% CI, 0.0001-0.002], and 0.008 [95% CI, 0.003-0.013], corresponding to relative IDIs of 12.8%, 6.3%, and 34.6%, respectively). These findings suggest that the incorporation of lung-specific risk factors into fracture risk assessment tools may more accurately predict fracture risk in smokers.
© 2020 American Society for Bone and Mineral Research. © 2020 American Society for Bone and Mineral Research.

Entities:  

Keywords:  FRACTURE RISK ASSESSMENT; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCREENING; SMOKING

Mesh:

Year:  2020        PMID: 32754944      PMCID: PMC8773459          DOI: 10.1002/jbmr.4103

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  47 in total

1.  Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis.

Authors:  Elizabeth F Shead; Charles S Haworth; Elaine Gunn; Diana Bilton; Mike A Scott; Juliet E Compston
Journal:  Am J Respir Crit Care Med       Date:  2006-05-04       Impact factor: 21.405

2.  Problems with risk reclassification methods for evaluating prediction models.

Authors:  Margaret S Pepe
Journal:  Am J Epidemiol       Date:  2011-05-09       Impact factor: 4.897

3.  Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study.

Authors:  Eric A Hoffman; Firas S Ahmed; Heather Baumhauer; Mathew Budoff; J Jeffrey Carr; Richard Kronmal; S Reddy; R Graham Barr
Journal:  Ann Am Thorac Soc       Date:  2014-07

4.  Lumbar spine bone mineral density in US adults: demographic patterns and relationship with femur neck skeletal status.

Authors:  A C Looker; L J Melton; L G Borrud; J A Shepherd
Journal:  Osteoporos Int       Date:  2011-07-01       Impact factor: 4.507

5.  Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.

Authors:  Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Pignone; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2018-06-26       Impact factor: 56.272

6.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

7.  The risk of osteoporosis in Caucasian men and women with obstructive airways disease.

Authors:  Don D Sin; Jonathan P Man; S F Paul Man
Journal:  Am J Med       Date:  2003-01       Impact factor: 4.965

8.  IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke.

Authors:  Kong Chen; Derek A Pociask; Jeremy P McAleer; Yvonne R Chan; John F Alcorn; James L Kreindler; Matthew R Keyser; Steven D Shapiro; A McGarry Houghton; Jay K Kolls; Mingquan Zheng
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

9.  Emphysema is associated with thoracic vertebral bone attenuation on chest CT scan in HIV-infected individuals.

Authors:  Alycia Petraglia; Joseph K Leader; Matthew Gingo; Meghan Fitzpatrick; John Ries; Cathy Kessinger; Lorrie Lucht; Danielle Camp; Alison Morris; Jessica Bon
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

10.  Atopic eczema and fracture risk in adults: A population-based cohort study.

Authors:  Katherine E Lowe; Kathryn E Mansfield; Antonella Delmestri; Liam Smeeth; Amanda Roberts; Katrina Abuabara; Daniel Prieto-Alhambra; Sinéad M Langan
Journal:  J Allergy Clin Immunol       Date:  2019-11-19       Impact factor: 10.793

View more
  2 in total

1.  Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET.

Authors:  Kathrin Kahnert; Rudolf A Jörres; Tanja Lucke; Franziska C Trudzinski; Pontus Mertsch; Christiane Bickert; Joachim H Ficker; Jürgen Behr; Robert Bals; Henrik Watz; Tobias Welte; Claus F Vogelmeier; Peter Alter
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-11-24

Review 2.  Osteoporosis in Patients With Respiratory Diseases.

Authors:  Yue Ma; Shui Qiu; Renyi Zhou
Journal:  Front Physiol       Date:  2022-07-12       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.